Logo image of SCANA.OL

SCANA ASA (SCANA.OL) Stock Fundamental Analysis

OSL:SCANA - Euronext Oslo - NO0003053308 - Common Stock - Currency: NOK

1.9  0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to SCANA. SCANA was compared to 103 industry peers in the Machinery industry. While SCANA belongs to the best of the industry regarding profitability, there are concerns on its financial health. SCANA is evaluated to be cheap and growing strongly. This does not happen too often!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

SCANA had positive earnings in the past year.
In the past year SCANA had a positive cash flow from operations.
SCANA had positive earnings in 4 of the past 5 years.
SCANA had a positive operating cash flow in each of the past 5 years.
SCANA.OL Yearly Net Income VS EBIT VS OCF VS FCFSCANA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

SCANA's Return On Assets of 5.30% is fine compared to the rest of the industry. SCANA outperforms 71.84% of its industry peers.
Looking at the Return On Equity, with a value of 12.56%, SCANA is in the better half of the industry, outperforming 74.76% of the companies in the same industry.
With an excellent Return On Invested Capital value of 10.69%, SCANA belongs to the best of the industry, outperforming 81.55% of the companies in the same industry.
Industry RankSector Rank
ROA 5.3%
ROE 12.56%
ROIC 10.69%
ROA(3y)2.29%
ROA(5y)7.89%
ROE(3y)5.28%
ROE(5y)21.93%
ROIC(3y)N/A
ROIC(5y)N/A
SCANA.OL Yearly ROA, ROE, ROICSCANA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1.3 Margins

SCANA has a Profit Margin (4.23%) which is in line with its industry peers.
In the last couple of years the Profit Margin of SCANA has grown nicely.
Looking at the Operating Margin, with a value of 7.49%, SCANA is in the better half of the industry, outperforming 63.11% of the companies in the same industry.
SCANA's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 53.34%, SCANA is doing good in the industry, outperforming 71.84% of the companies in the same industry.
SCANA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.49%
PM (TTM) 4.23%
GM 53.34%
OM growth 3Y35.21%
OM growth 5Y249.35%
PM growth 3Y-21.66%
PM growth 5Y10.48%
GM growth 3Y6.46%
GM growth 5Y7.06%
SCANA.OL Yearly Profit, Operating, Gross MarginsSCANA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

2

2. Health

2.1 Basic Checks

SCANA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
SCANA has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SCANA has been increased compared to 5 years ago.
Compared to 1 year ago, SCANA has an improved debt to assets ratio.
SCANA.OL Yearly Shares OutstandingSCANA.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
SCANA.OL Yearly Total Debt VS Total AssetsSCANA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

The Debt to FCF ratio of SCANA is 7.37, which is on the high side as it means it would take SCANA, 7.37 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.37, SCANA is in line with its industry, outperforming 48.54% of the companies in the same industry.
SCANA has a Debt/Equity ratio of 0.57. This is a neutral value indicating SCANA is somewhat dependend on debt financing.
SCANA has a Debt to Equity ratio (0.57) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 7.37
Altman-Z N/A
ROIC/WACC1.34
WACC7.97%
SCANA.OL Yearly LT Debt VS Equity VS FCFSCANA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

SCANA has a Current Ratio of 1.12. This is a normal value and indicates that SCANA is financially healthy and should not expect problems in meeting its short term obligations.
SCANA has a worse Current ratio (1.12) than 76.70% of its industry peers.
SCANA has a Quick Ratio of 1.12. This is a bad value and indicates that SCANA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.93, SCANA perfoms like the industry average, outperforming 43.69% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.93
SCANA.OL Yearly Current Assets VS Current LiabilitesSCANA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

8

3. Growth

3.1 Past

SCANA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.46%.
The Earnings Per Share has been growing by 20.84% on average over the past years. This is a very strong growth
The Revenue has grown by 22.66% in the past year. This is a very strong growth!
Measured over the past years, SCANA shows a very strong growth in Revenue. The Revenue has been growing by 40.40% on average per year.
EPS 1Y (TTM)5.46%
EPS 3Y-9.67%
EPS 5Y20.84%
EPS Q2Q%-36.17%
Revenue 1Y (TTM)22.66%
Revenue growth 3Y86.39%
Revenue growth 5Y40.4%
Sales Q2Q%8.76%

3.2 Future

The Earnings Per Share is expected to grow by 34.80% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 10.21% on average over the next years. This is quite good.
EPS Next Y19.33%
EPS Next 2Y39.53%
EPS Next 3Y34.8%
EPS Next 5YN/A
Revenue Next Year1.92%
Revenue Next 2Y9.54%
Revenue Next 3Y10.21%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SCANA.OL Yearly Revenue VS EstimatesSCANA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
SCANA.OL Yearly EPS VS EstimatesSCANA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.88, the valuation of SCANA can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of SCANA indicates a somewhat cheap valuation: SCANA is cheaper than 70.87% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 28.79. SCANA is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 9.71, the valuation of SCANA can be described as very reasonable.
Based on the Price/Forward Earnings ratio, SCANA is valued a bit cheaper than the industry average as 76.70% of the companies are valued more expensively.
SCANA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.38.
Industry RankSector Rank
PE 11.88
Fwd PE 9.71
SCANA.OL Price Earnings VS Forward Price EarningsSCANA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

SCANA's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SCANA is cheaper than 76.70% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, SCANA is valued a bit cheaper than the industry average as 68.93% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.4
EV/EBITDA 5.19
SCANA.OL Per share dataSCANA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SCANA has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as SCANA's earnings are expected to grow with 34.80% in the coming years.
PEG (NY)0.61
PEG (5Y)0.57
EPS Next 2Y39.53%
EPS Next 3Y34.8%

4

5. Dividend

5.1 Amount

SCANA has a Yearly Dividend Yield of 2.63%. Purely for dividend investing, there may be better candidates out there.
In the last 3 months the price of SCANA has falen by -30.15%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
SCANA's Dividend Yield is a higher than the industry average which is at 2.65.
SCANA's Dividend Yield is comparable with the S&P500 average which is at 2.47.
Industry RankSector Rank
Dividend Yield 2.63%

5.2 History

The dividend of SCANA decreases each year by -61.68%.
Dividend Growth(5Y)-61.68%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

SCANA pays out 27.13% of its income as dividend. This is a sustainable payout ratio.
DP27.13%
EPS Next 2Y39.53%
EPS Next 3Y34.8%
SCANA.OL Yearly Income VS Free CF VS DividendSCANA.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M
SCANA.OL Dividend Payout.SCANA.OL Dividend Payout, showing the Payout Ratio.SCANA.OL Dividend Payout.PayoutRetained Earnings

SCANA ASA

OSL:SCANA (4/25/2025, 7:00:00 PM)

1.9

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-27 2025-02-27/bmo
Earnings (Next)N/A N/A
Inst Owners0.14%
Inst Owner ChangeN/A
Ins Owners9.84%
Ins Owner ChangeN/A
Market Cap877.59M
Analysts86.67
Price Target3.47 (82.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.63%
Yearly Dividend0.05
Dividend Growth(5Y)-61.68%
DP27.13%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)11.65%
Min EPS beat(2)-2.91%
Max EPS beat(2)26.21%
EPS beat(4)2
Avg EPS beat(4)13.67%
Min EPS beat(4)-96.76%
Max EPS beat(4)128.16%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-5.45%
Min Revenue beat(2)-11.67%
Max Revenue beat(2)0.77%
Revenue beat(4)3
Avg Revenue beat(4)5.62%
Min Revenue beat(4)-11.67%
Max Revenue beat(4)23.76%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-13.64%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 11.88
Fwd PE 9.71
P/S 0.45
P/FCF 13.4
P/OCF 5.99
P/B 1.32
P/tB 3.13
EV/EBITDA 5.19
EPS(TTM)0.16
EY8.42%
EPS(NY)0.2
Fwd EY10.3%
FCF(TTM)0.14
FCFY7.46%
OCF(TTM)0.32
OCFY16.69%
SpS4.27
BVpS1.44
TBVpS0.61
PEG (NY)0.61
PEG (5Y)0.57
Profitability
Industry RankSector Rank
ROA 5.3%
ROE 12.56%
ROCE 14.11%
ROIC 10.69%
ROICexc 10.77%
ROICexgc 17.06%
OM 7.49%
PM (TTM) 4.23%
GM 53.34%
FCFM 3.32%
ROA(3y)2.29%
ROA(5y)7.89%
ROE(3y)5.28%
ROE(5y)21.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y8.14%
ROICexcg growth 5Y203.17%
ROICexc growth 3Y-6.18%
ROICexc growth 5Y178.96%
OM growth 3Y35.21%
OM growth 5Y249.35%
PM growth 3Y-21.66%
PM growth 5Y10.48%
GM growth 3Y6.46%
GM growth 5Y7.06%
F-Score8
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 7.37
Debt/EBITDA 1.46
Cap/Depr 71.68%
Cap/Sales 4.11%
Interest Coverage 3.83
Cash Conversion 56.22%
Profit Quality 78.63%
Current Ratio 1.12
Quick Ratio 0.93
Altman-Z N/A
F-Score8
WACC7.97%
ROIC/WACC1.34
Cap/Depr(3y)42.24%
Cap/Depr(5y)32.52%
Cap/Sales(3y)2.78%
Cap/Sales(5y)1.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.46%
EPS 3Y-9.67%
EPS 5Y20.84%
EPS Q2Q%-36.17%
EPS Next Y19.33%
EPS Next 2Y39.53%
EPS Next 3Y34.8%
EPS Next 5YN/A
Revenue 1Y (TTM)22.66%
Revenue growth 3Y86.39%
Revenue growth 5Y40.4%
Sales Q2Q%8.76%
Revenue Next Year1.92%
Revenue Next 2Y9.54%
Revenue Next 3Y10.21%
Revenue Next 5YN/A
EBIT growth 1Y77.19%
EBIT growth 3Y152.01%
EBIT growth 5Y390.48%
EBIT Next Year82.48%
EBIT Next 3Y36.44%
EBIT Next 5YN/A
FCF growth 1Y-47.68%
FCF growth 3Y41.29%
FCF growth 5Y3.96%
OCF growth 1Y-7.22%
OCF growth 3Y80.15%
OCF growth 5Y20.9%